Cargando…
ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313407/ https://www.ncbi.nlm.nih.gov/pubmed/34297039 http://dx.doi.org/10.1084/jem.20201833 |
_version_ | 1783729340854304768 |
---|---|
author | Herzner, Anna-Maria Khan, Zia Van Nostrand, Eric L. Chan, Sara Cuellar, Trinna Chen, Ronald Pechuan-Jorge, Ximo Komuves, Laszlo Solon, Margaret Modrusan, Zora Haley, Benjamin Yeo, Gene W. Behrens, Timothy W. Albert, Matthew L. |
author_facet | Herzner, Anna-Maria Khan, Zia Van Nostrand, Eric L. Chan, Sara Cuellar, Trinna Chen, Ronald Pechuan-Jorge, Ximo Komuves, Laszlo Solon, Margaret Modrusan, Zora Haley, Benjamin Yeo, Gene W. Behrens, Timothy W. Albert, Matthew L. |
author_sort | Herzner, Anna-Maria |
collection | PubMed |
description | Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element–induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy. |
format | Online Article Text |
id | pubmed-8313407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83134072021-08-05 ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses Herzner, Anna-Maria Khan, Zia Van Nostrand, Eric L. Chan, Sara Cuellar, Trinna Chen, Ronald Pechuan-Jorge, Ximo Komuves, Laszlo Solon, Margaret Modrusan, Zora Haley, Benjamin Yeo, Gene W. Behrens, Timothy W. Albert, Matthew L. J Exp Med Article Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element–induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy. Rockefeller University Press 2021-07-23 /pmc/articles/PMC8313407/ /pubmed/34297039 http://dx.doi.org/10.1084/jem.20201833 Text en © 2021 Genentech, Inc. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Herzner, Anna-Maria Khan, Zia Van Nostrand, Eric L. Chan, Sara Cuellar, Trinna Chen, Ronald Pechuan-Jorge, Ximo Komuves, Laszlo Solon, Margaret Modrusan, Zora Haley, Benjamin Yeo, Gene W. Behrens, Timothy W. Albert, Matthew L. ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses |
title | ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses |
title_full | ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses |
title_fullStr | ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses |
title_full_unstemmed | ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses |
title_short | ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses |
title_sort | adar and hnrnpc deficiency synergize in activating endogenous dsrna-induced type i ifn responses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313407/ https://www.ncbi.nlm.nih.gov/pubmed/34297039 http://dx.doi.org/10.1084/jem.20201833 |
work_keys_str_mv | AT herznerannamaria adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT khanzia adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT vannostrandericl adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT chansara adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT cuellartrinna adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT chenronald adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT pechuanjorgeximo adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT komuveslaszlo adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT solonmargaret adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT modrusanzora adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT haleybenjamin adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT yeogenew adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT behrenstimothyw adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses AT albertmatthewl adarandhnrnpcdeficiencysynergizeinactivatingendogenousdsrnainducedtypeiifnresponses |